{"id":{"repo_id":"glasgow","oai_identifier":"oai:theses.gla.ac.uk:76979"},"canonical_url":"https://search.ndltd.org/etd/glasgow/oai:theses.gla.ac.uk:76979","repository":{"repo_id":"glasgow","name":"University of Glasgow","base_url":"https://theses.gla.ac.uk/cgi/oai2"},"display":{"title":"Clinical and immunological assessment of high dose combination therapy and autologous bone marrow transplantation in the haematological malignancies","abstract":"The studies described were performed on samples obtained from patients undergoing high dose therapy and autologous bone marrow transplantation at University College and Middlesex Hospital School of Medicine between 1986 and 1989. Since 1981 a total of 227 patients have undergone autologous bone marrow transplantation for the haematological malignancies acute myeloid leukaemia (AML), acute lymphoblastic leukaemia (ALL), Hodgkin's disease (HD) and Non-Hodgkin's Lymphoma (NHL) and are available for analysis of clinical results. The clinical results obtained in each patient group are described in the first chapter.","abstract_html":"The studies described were performed on samples obtained from patients undergoing high dose therapy and autologous bone marrow transplantation at University College and Middlesex Hospital School of Medicine between 1986 and 1989. Since 1981 a total of 227 patients have undergone autologous bone marrow transplantation for the haematological malignancies acute myeloid leukaemia (AML), acute lymphoblastic leukaemia (ALL), Hodgkin&#x27;s disease (HD) and Non-Hodgkin&#x27;s Lymphoma (NHL) and are available for analysis of clinical results. The clinical results obtained in each patient group are described in the first chapter.","abstract_has_math":false,"creators":["Gribben, John G."],"institution":"University of Glasgow","degree_name":null,"degree_level":"MD","degree_discipline":null,"degree_department":null,"school":null,"contributors":[],"advisors":[],"committee_chairs":[],"committee_members":[],"year":1990,"date_issued":"1990","date_published":"1990","updated_at":"2026-11-19T08:31:33Z","subjects":["QR Microbiology","RC0254 Neoplasms. Tumors. Oncology (including Cancer)","RM Therapeutics. Pharmacology"],"languages":["en"],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":"https://doi.org/10.5525/gla.thesis.76979","outbound_label":"DOI","outbound_source":"dc:identifier.doi","record_url":"https://doi.org/10.5525/gla.thesis.76979","record_label":"Repository record","record_kind":"doi","record_source":"dc:identifier.doi","download_url":"https://theses.gla.ac.uk/76979/7/10983567.pdf","download_label":"Download PDF","download_source":"dc:identifier.uri","access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://theses.gla.ac.uk/cgi/oai2?verb=GetRecord&metadataPrefix=uketd_dc&identifier=oai%3Atheses.gla.ac.uk%3A76979","prefix":"uketd_dc"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:creator","label":"Author","values":["Gribben, John G."]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["1990"]},{"key":"dc:date.issued","label":"Date","values":["1990"]},{"key":"dc:publisher.commercial","label":"Dc Publisher Commercial","values":["ProQuest Dissertations & Theses,"]},{"key":"dc:publisher.department","label":"Dc Publisher Department","values":["Department of Haematology."]},{"key":"dc:publisher.institution","label":"Dc Publisher Institution","values":["University of Glasgow"]},{"key":"dc:relation.isreferencedby","label":"Dc Relation Isreferencedby","values":["https://theses.gla.ac.uk/76979/"]},{"key":"dc:relation.isreferencedby.uri","label":"Dc Relation Isreferencedby URI","values":["https://gla.on.worldcat.org/oclc/181840871"]},{"key":"dc:type","label":"Dc Type","values":["Thesis"]},{"key":"dc:type.qualificationlevel","label":"Dc Type Qualificationlevel","values":["MD"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["QR Microbiology","RC0254 Neoplasms. Tumors. Oncology (including Cancer)","RM Therapeutics. Pharmacology"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["en"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.doi","label":"DOI","values":["10.5525/gla.thesis.76979"]},{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://theses.gla.ac.uk/76979/7/10983567.pdf"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["The studies described were performed on samples obtained from patients undergoing high dose therapy and autologous bone marrow transplantation at University College and Middlesex Hospital School of Medicine between 1986 and 1989. Since 1981 a total of 227 patients have undergone autologous bone marrow transplantation for the haematological malignancies acute myeloid leukaemia (AML), acute lymphoblastic leukaemia (ALL), Hodgkin's disease (HD) and Non-Hodgkin's Lymphoma (NHL) and are available for analysis of clinical results. The clinical results obtained in each patient group are described in the first chapter."]},{"key":"dc:format","label":"Dc Format","values":["pdf"]},{"key":"dcterms:accessrights","label":"Dcterms Accessrights","values":["public"]},{"key":"dc:title","label":"Title","values":["Clinical and immunological assessment of high dose combination therapy and autologous bone marrow transplantation in the haematological malignancies"]}]}],"canonical_facts":{"dc:creator":["Gribben, John G."],"dc:date":["1990"],"dc:date.issued":["1990"],"dc:description.abstract":["The studies described were performed on samples obtained from patients undergoing high dose therapy and autologous bone marrow transplantation at University College and Middlesex Hospital School of Medicine between 1986 and 1989. Since 1981 a total of 227 patients have undergone autologous bone marrow transplantation for the haematological malignancies acute myeloid leukaemia (AML), acute lymphoblastic leukaemia (ALL), Hodgkin's disease (HD) and Non-Hodgkin's Lymphoma (NHL) and are available for analysis of clinical results. The clinical results obtained in each patient group are described in the first chapter."],"dc:format":["pdf"],"dc:identifier.doi":["10.5525/gla.thesis.76979"],"dc:identifier.uri":["https://theses.gla.ac.uk/76979/7/10983567.pdf"],"dc:language":["en"],"dc:publisher.commercial":["ProQuest Dissertations & Theses,"],"dc:publisher.department":["Department of Haematology."],"dc:publisher.institution":["University of Glasgow"],"dc:relation.isreferencedby":["https://theses.gla.ac.uk/76979/"],"dc:relation.isreferencedby.uri":["https://gla.on.worldcat.org/oclc/181840871"],"dc:subject":["QR Microbiology","RC0254 Neoplasms. Tumors. Oncology (including Cancer)","RM Therapeutics. Pharmacology"],"dcterms:accessrights":["public"],"dc:title":["Clinical and immunological assessment of high dose combination therapy and autologous bone marrow transplantation in the haematological malignancies"],"dc:type":["Thesis"],"dc:type.qualificationlevel":["MD"]},"updated_at":"2026-11-19T08:31:33Z"}